115 related articles for article (PubMed ID: 7522727)
1. Autologous bone marrow transplantation for myeloma patients using PNA- and CD19-purged marrow rescue.
Rhodes EG; Baker PK; Rhodes JM; Davies JM; Duguid JK
Bone Marrow Transplant; 1994 Jun; 13(6):795-9. PubMed ID: 7522727
[TBL] [Abstract][Full Text] [Related]
2. Peanut agglutinin in combination with CD19 monoclonal antibody has potential as a purging agent in myeloma.
Rhodes EG; Baker P; Rhodes JM; Davies JM; Cawley JC
Exp Hematol; 1991 Sep; 19(8):833-7. PubMed ID: 1714405
[TBL] [Abstract][Full Text] [Related]
3. A method for clinical purging of myeloma bone marrow using peanut agglutinin as an anti-plasma cell agent, in combination with CD19 monoclonal antibody.
Rhodes EG; Baker PK; Duguid JK; Davies JM; Cawley JC
Bone Marrow Transplant; 1992 Dec; 10(6):485-9. PubMed ID: 1490198
[TBL] [Abstract][Full Text] [Related]
4. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow.
Ericson SG; Colby E; Welch L; Ball ED
Bone Marrow Transplant; 1992 Feb; 9(2):129-37. PubMed ID: 1373982
[TBL] [Abstract][Full Text] [Related]
5. Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission.
Gilmore MJ; Hamon MD; Prentice HG; Katz F; Slaper-Cortenbach IC; Hunter AE; Gandhi L; Brenner MK; Hoffbrand AV; Mehta AB
Bone Marrow Transplant; 1991 Jul; 8(1):19-26. PubMed ID: 1717092
[TBL] [Abstract][Full Text] [Related]
6. The synthesis of a peanut agglutinin-ricin A chain conjugate: potential as an in vitro purging agent for autologous bone marrow in multiple myeloma.
Lazzaro GE; Meyer BF; Willis JI; Erber WN; Herrmann RP; Davies JM
Exp Hematol; 1995 Dec; 23(13):1347-52. PubMed ID: 7498362
[TBL] [Abstract][Full Text] [Related]
7. Peanut agglutinin purging and magnetic microspheres.
Rhodes EG; Baker PK; Duguid JK; Cawley JC
Prog Clin Biol Res; 1992; 377():139-46. PubMed ID: 1438410
[No Abstract] [Full Text] [Related]
8. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow transplantation for B cell malignancies after in vitro purging with floating immunobeads.
Stoppa AM; Hirn J; Blaise D; Delaage M; Novakovitch G; Viens P; Capiello MA; Mannoni P; Mawas C; Maraninchi D
Bone Marrow Transplant; 1990 Nov; 6(5):301-7. PubMed ID: 2291992
[TBL] [Abstract][Full Text] [Related]
10. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies.
De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A
Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552
[TBL] [Abstract][Full Text] [Related]
11. Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.
Reece DE; Barnett MJ; Connors JM; Klingemann HG; O'Reilly SE; Shepherd JD; Sutherland HJ; Phillips GL
Bone Marrow Transplant; 1993 Feb; 11(2):139-46. PubMed ID: 8435663
[TBL] [Abstract][Full Text] [Related]
12. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
Waddick KG; Uckun FM
Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of monoclonal antibodies (MoAbs) for the ex vivo purging of the bone marrow in patients with multiple myeloma.
Dinota A; Tazzari PL; Bontadini A; Grassi GP; Cerato C; Motta MR; Visani G; Cavo M; Gobbi M; Tura S
J Exp Pathol; 1987; 3(4):363-7. PubMed ID: 3331648
[No Abstract] [Full Text] [Related]
14. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.
Soiffer RJ; Roy DC; Gonin R; Murray C; Anderson KC; Freedman AS; Rabinowe SN; Robertson MJ; Spector N; Pesek K
Bone Marrow Transplant; 1993 Sep; 12(3):243-51. PubMed ID: 8241984
[TBL] [Abstract][Full Text] [Related]
15. Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia.
Schmid H; Henze G; Schwerdtfeger R; Baumgarten E; Besserer A; Scheffler A; Serke S; Zingsem J; Siegert W
Bone Marrow Transplant; 1993 Dec; 12(6):597-602. PubMed ID: 8136744
[TBL] [Abstract][Full Text] [Related]
16. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
Mehta J; Powles R; Singhal S; Horton C; Tait D; Treleaven J
Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma.
Seiden MV; Schlossman R; Andersen J; Freeman A; Robertson M; Soiffer R; Freedman A; Mauch P; Ritz J; Nadler L
Leuk Lymphoma; 1995 Mar; 17(1-2):87-93. PubMed ID: 7773166
[TBL] [Abstract][Full Text] [Related]
19. Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
Reece DE; Brockington DA; Phillips GL; Barnett MJ; Klingemann HG; Nantel SH; Sutherland HJ; Shepherd JD
Bone Marrow Transplant; 2000 Sep; 26(6):621-6. PubMed ID: 11041567
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up.
Ball ED; Wilson J; Phelps V; Neudorf S
Bone Marrow Transplant; 2000 Apr; 25(8):823-9. PubMed ID: 10808202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
